Sources | Names Used |
---|---|
CTRPv2 | YL54 |
PharmacoGx | YL54 |
Database | Identifier |
---|---|
Smiles: | CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@]1(C)CCCC=C/CCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
mRNA | RP11-140L24.4 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
mRNA | WBP1L | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
mRNA | ASPHD2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
mRNA | PTDSS1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
mRNA | SLC25A24 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
mRNA | ATP12A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
mRNA | IQSEC1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
mRNA | CEP57 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
mRNA | HS6ST3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |